Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-071611
Filing Date
2024-06-11
Accepted
2024-06-11 06:52:06
Documents
17
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 6-K 6-k_agm_pr_announcement_.htm 6-K 24678
2 EX-99.1 phvs-ex99_1.htm EX-99.1 6752
3 EX-99.2 phvs-ex99_2.htm EX-99.2 63796
4 EX-99.3 phvs-ex99_3.htm EX-99.3 38461
5 EX-99.4 phvs-ex99_4.htm EX-99.4 3865170
6 GRAPHIC img30888848_0.jpg GRAPHIC 46382
7 GRAPHIC img33659411_0.jpg GRAPHIC 35787
8 GRAPHIC img33659411_1.jpg GRAPHIC 66743
9 GRAPHIC img33659411_2.jpg GRAPHIC 15839
10 GRAPHIC img33659411_3.jpg GRAPHIC 14764
11 GRAPHIC img33659411_4.jpg GRAPHIC 7527
12 GRAPHIC img33659411_5.jpg GRAPHIC 20800
13 GRAPHIC img33659411_6.jpg GRAPHIC 15149
14 GRAPHIC img33659411_7.jpg GRAPHIC 58236
15 GRAPHIC img33659411_8.jpg GRAPHIC 34910
16 GRAPHIC img33659411_9.jpg GRAPHIC 117618
17 GRAPHIC img33659411_10.jpg GRAPHIC 11708
  Complete submission text file 0000950170-24-071611.txt   4614612
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40010 | Film No.: 241034590
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)